Discounted Cash Flow (DCF) Analysis Levered

Healthcare Special Opportunities Fu... (MDS-UN.TO)

$11.84

+0.53 (+0.00%)
All numbers are in Millions, Currency in USD

Free Cash Flow

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Revenue 8.235.155.822.121.531.090.770.550.390.28
Revenue (%)
Operating Cash Flow 29.5811.503.351.853.722.111.501.070.760.54
Operating Cash Flow (%)
Capital Expenditure ----------
Capital Expenditure (%)
Free Cash Flow -----2.111.501.070.760.54

Weighted Average Cost Of Capital

Share price $ 11.84
Beta 0.000
Diluted Shares Outstanding 2.63
Cost of Debt
Tax Rate 3.10
After-tax Cost of Debt -%
Risk-Free Rate
Market Risk Premium
Cost of Equity 4.542
Total Debt -
Total Equity 31.14
Total Capital -
Debt Weighting -
Equity Weighting -
Wacc

Build Up Free Cash Flow

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Revenue 8.235.155.822.121.531.090.770.550.390.28
Operating Cash Flow 29.5811.503.351.853.722.111.501.070.760.54
Capital Expenditure ----------
Free Cash Flow -----2.111.501.070.760.54
WACC
PV LFCF -----
SUM PV LFCF -

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) -
Free cash flow (t + 1) 0.55
Terminal Value -
Present Value of Terminal Value -

Intrinsic Value

Enterprise Value -
Net Debt -3.33
Equity Value -
Shares Outstanding 2.63
Equity Value Per Share -